| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aryl hydrocarbon receptor binding | 1.80e-06 | 9 | 5 | 2 | GO:0017162 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 3.81e-03 | 398 | 5 | 2 | GO:0046982 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.17e-03 | 417 | 5 | 2 | GO:0061629 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 5.43e-03 | 477 | 5 | 2 | GO:0022804 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 8.00e-03 | 582 | 5 | 2 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.32e-02 | 753 | 5 | 2 | GO:0008134 | |
| GeneOntologyCellularComponent | aryl hydrocarbon receptor complex | 1.28e-06 | 8 | 5 | 2 | GO:0034751 | |
| GeneOntologyCellularComponent | receptor complex | 7.29e-03 | 581 | 5 | 2 | GO:0043235 | |
| GeneOntologyCellularComponent | transcription regulator complex | 7.66e-03 | 596 | 5 | 2 | GO:0005667 | |
| Domain | Nuc_translocat | 1.60e-06 | 8 | 5 | 2 | IPR001067 | |
| Domain | PAS_3 | 1.45e-05 | 23 | 5 | 2 | PF08447 | |
| Domain | PAS_fold_3 | 1.45e-05 | 23 | 5 | 2 | IPR013655 | |
| Domain | PAS-assoc_C | 1.58e-05 | 24 | 5 | 2 | IPR000700 | |
| Domain | PAS | 1.72e-05 | 25 | 5 | 2 | PF00989 | |
| Domain | PAS_fold | 1.72e-05 | 25 | 5 | 2 | IPR013767 | |
| Domain | PAC | 1.86e-05 | 26 | 5 | 2 | IPR001610 | |
| Domain | PAC | 1.86e-05 | 26 | 5 | 2 | SM00086 | |
| Domain | PAC | 1.86e-05 | 26 | 5 | 2 | PS50113 | |
| Domain | PAS | 2.83e-05 | 32 | 5 | 2 | SM00091 | |
| Domain | PAS | 3.21e-05 | 34 | 5 | 2 | IPR000014 | |
| Domain | PAS | 3.21e-05 | 34 | 5 | 2 | PS50112 | |
| Domain | - | 3.34e-04 | 109 | 5 | 2 | 4.10.280.10 | |
| Domain | HLH | 3.46e-04 | 111 | 5 | 2 | PF00010 | |
| Domain | HLH | 3.78e-04 | 116 | 5 | 2 | SM00353 | |
| Domain | BHLH | 3.84e-04 | 117 | 5 | 2 | PS50888 | |
| Domain | bHLH_dom | 3.91e-04 | 118 | 5 | 2 | IPR011598 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 6.04e-07 | 5 | 4 | 2 | MM16637 | |
| Pathway | REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING | 9.05e-07 | 6 | 4 | 2 | M27793 | |
| Pathway | REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING | 1.27e-06 | 7 | 4 | 2 | MM15528 | |
| Pathway | REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES | 1.39e-05 | 22 | 4 | 2 | M46437 | |
| Pathway | REACTOME_XENOBIOTICS | 1.52e-05 | 23 | 4 | 2 | M5372 | |
| Pathway | REACTOME_XENOBIOTICS | 1.81e-05 | 25 | 4 | 2 | MM14846 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 1.81e-05 | 25 | 4 | 2 | M11184 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 2.11e-05 | 27 | 4 | 2 | MM14844 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 3.38e-05 | 34 | 4 | 2 | M39771 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 3.38e-05 | 34 | 4 | 2 | M46422 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.21e-04 | 64 | 4 | 2 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.29e-04 | 66 | 4 | 2 | MM14839 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 1.45e-04 | 70 | 4 | 2 | M13266 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 3.20e-04 | 104 | 4 | 2 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 3.27e-04 | 105 | 4 | 2 | MM14842 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 4.12e-04 | 118 | 4 | 2 | M27316 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 1.19e-03 | 201 | 4 | 2 | M39605 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.41e-03 | 219 | 4 | 2 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.42e-03 | 220 | 4 | 2 | M10320 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 3.08e-03 | 325 | 4 | 2 | M12868 | |
| Pathway | WP_CANCER_PATHWAYS | 7.38e-03 | 507 | 4 | 2 | M48302 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 1.61e-02 | 757 | 4 | 2 | M27451 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 1.65e-02 | 768 | 4 | 2 | MM14851 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 2.85e-02 | 1022 | 4 | 2 | MM15436 | |
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 17023418 | ||
| Pubmed | 1.65e-08 | 2 | 5 | 2 | 15466261 | ||
| Pubmed | Expression of Arnt and Arnt2 mRNA in developing murine tissues. | 4.96e-08 | 3 | 5 | 2 | 12502753 | |
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 36343253 | ||
| Pubmed | 4.96e-08 | 3 | 5 | 2 | 8657146 | ||
| Pubmed | Analysis of Ah receptor-ARNT and Ah receptor-ARNT2 complexes in vitro and in cell culture. | 4.96e-08 | 3 | 5 | 2 | 18096572 | |
| Pubmed | Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. | 1.65e-07 | 5 | 5 | 2 | 9545558 | |
| Pubmed | 2.48e-07 | 6 | 5 | 2 | 11025203 | ||
| Pubmed | 2.48e-07 | 6 | 5 | 2 | 8927054 | ||
| Pubmed | Separate necdin domains bind ARNT2 and HIF1alpha and repress transcription. | 2.48e-07 | 6 | 5 | 2 | 17826745 | |
| Pubmed | 3.47e-07 | 7 | 5 | 2 | 27782878 | ||
| Pubmed | 3.47e-07 | 7 | 5 | 2 | 14701734 | ||
| Pubmed | MAGED1 is a novel regulator of a select subset of bHLH PAS transcription factors. | 3.47e-07 | 7 | 5 | 2 | 27472814 | |
| Pubmed | 4.63e-07 | 8 | 5 | 2 | 11782478 | ||
| Pubmed | HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature. | 7.44e-07 | 10 | 5 | 2 | 16824955 | |
| Pubmed | 9.09e-07 | 11 | 5 | 2 | 11381139 | ||
| Pubmed | 3.14e-06 | 20 | 5 | 2 | 20495570 | ||
| Pubmed | 3.53e-05 | 66 | 5 | 2 | 23275444 | ||
| Pubmed | 7.82e-05 | 98 | 5 | 2 | 18557763 | ||
| Pubmed | 1.29e-04 | 126 | 5 | 2 | 16284245 | ||
| Interaction | NPAS4 interactions | 4.43e-07 | 6 | 4 | 2 | int:NPAS4 | |
| Interaction | SIM1 interactions | 8.27e-07 | 8 | 4 | 2 | int:SIM1 | |
| Interaction | NPAS3 interactions | 1.06e-06 | 9 | 4 | 2 | int:NPAS3 | |
| Interaction | NR6A1 interactions | 8.14e-06 | 24 | 4 | 2 | int:NR6A1 | |
| Interaction | SIM2 interactions | 8.85e-06 | 25 | 4 | 2 | int:SIM2 | |
| Interaction | NPAS2 interactions | 2.54e-05 | 42 | 4 | 2 | int:NPAS2 | |
| Interaction | TFEB interactions | 3.91e-05 | 52 | 4 | 2 | int:TFEB | |
| Interaction | LDB2 interactions | 4.53e-05 | 56 | 4 | 2 | int:LDB2 | |
| Interaction | NR4A3 interactions | 6.90e-05 | 69 | 4 | 2 | int:NR4A3 | |
| Interaction | TFAP2D interactions | 1.15e-04 | 89 | 4 | 2 | int:TFAP2D | |
| Interaction | ARNT2 interactions | 1.51e-04 | 102 | 4 | 2 | int:ARNT2 | |
| Interaction | AHR interactions | 2.53e-04 | 132 | 4 | 2 | int:AHR | |
| Interaction | TACC3 interactions | 3.18e-04 | 148 | 4 | 2 | int:TACC3 | |
| Interaction | TCF12 interactions | 3.18e-04 | 148 | 4 | 2 | int:TCF12 | |
| Interaction | EPAS1 interactions | 4.35e-04 | 173 | 4 | 2 | int:EPAS1 | |
| Interaction | TEAD1 interactions | 4.50e-04 | 176 | 4 | 2 | int:TEAD1 | |
| Interaction | CALML3 interactions | 7.66e-04 | 230 | 4 | 2 | int:CALML3 | |
| Interaction | NPAS1 interactions | 8.69e-04 | 245 | 4 | 2 | int:NPAS1 | |
| Interaction | ARNT interactions | 9.41e-04 | 255 | 4 | 2 | int:ARNT | |
| Interaction | TCF7L2 interactions | 1.17e-03 | 285 | 4 | 2 | int:TCF7L2 | |
| Interaction | NCOR1 interactions | 1.90e-03 | 363 | 4 | 2 | int:NCOR1 | |
| Interaction | SIN3A interactions | 2.07e-03 | 380 | 4 | 2 | int:SIN3A | |
| Interaction | WWTR1 interactions | 2.55e-03 | 422 | 4 | 2 | int:WWTR1 | |
| Interaction | ABT1 interactions | 2.56e-03 | 423 | 4 | 2 | int:ABT1 | |
| Interaction | HIF1A interactions | 2.78e-03 | 441 | 4 | 2 | int:HIF1A | |
| Interaction | NDN interactions | 2.94e-03 | 453 | 4 | 2 | int:NDN | |
| Interaction | CREBBP interactions | 5.09e-03 | 599 | 4 | 2 | int:CREBBP | |
| Interaction | TRIM37 interactions | 5.61e-03 | 630 | 4 | 2 | int:TRIM37 | |
| GeneFamily | Basic helix-loop-helix proteins | 3.62e-04 | 110 | 5 | 2 | 420 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 5.15e-04 | 190 | 5 | 2 | M8457 | |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP | 5.59e-04 | 198 | 5 | 2 | M3129 | |
| Coexpression | GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP | 5.71e-04 | 200 | 5 | 2 | M9023 | |
| Coexpression | KYNG_DNA_DAMAGE_UP | 5.99e-04 | 205 | 5 | 2 | M3961 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.09e-07 | 168 | 5 | 3 | 17d46f993dc4ae22b8087808582aba77f5c61892 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.11e-05 | 129 | 5 | 2 | b0c3cbab552e1d540e6b03a691dd245f81715e0b | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.75e-05 | 134 | 5 | 2 | 3b67c02b430b6d58467f36e606c478d3eea0063f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 157 | 5 | 2 | c779a53b2c67d566f5d417e753cd17196a6bfd1c | |
| ToppCell | AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.67e-04 | 185 | 5 | 2 | 3b3268e3f99121124e33086cac88479808d31630 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 188 | 5 | 2 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 188 | 5 | 2 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.72e-04 | 188 | 5 | 2 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 189 | 5 | 2 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 189 | 5 | 2 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 190 | 5 | 2 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | tumor_Lung-Epithelial_cells-tS1|tumor_Lung / Location, Cell class and cell subclass | 1.89e-04 | 197 | 5 | 2 | 8336e6647604e4bdd1596ea554c22203d13782e9 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS1|Epithelial_cells / Location, Cell class and cell subclass | 1.89e-04 | 197 | 5 | 2 | 7190143468939cf26c069d125a5e88e4bf026299 | |
| Drug | 11-fluoro-7-(14,14,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl)estra-1,3-5(10)-triene-3,17-diol | 1.39e-06 | 9 | 5 | 2 | ctd:C541120 | |
| Drug | 2-acetamidoacrylate | 2.12e-06 | 11 | 5 | 2 | CID000079482 | |
| Drug | 1,3-dinitropyrene | 4.05e-06 | 15 | 5 | 2 | CID000053230 | |
| Drug | 2-nitrofluoranthene | 5.89e-06 | 18 | 5 | 2 | CID000025760 | |
| Drug | HAHs | 6.59e-06 | 19 | 5 | 2 | CID003035605 | |
| Drug | 6-nitrochrysene | 8.90e-06 | 22 | 5 | 2 | CID000024121 | |
| Drug | hexachlorodibenzo-p-dioxin | 1.06e-05 | 24 | 5 | 2 | CID000038251 | |
| Drug | 1-aminopyrene | 1.16e-05 | 25 | 5 | 2 | CID000015352 | |
| Drug | 3-nitrofluoranthene | 1.25e-05 | 26 | 5 | 2 | CID000013462 | |
| Drug | PeCDD | 1.35e-05 | 27 | 5 | 2 | CID000038439 | |
| Drug | MCDF | 1.46e-05 | 28 | 5 | 2 | CID000114900 | |
| Drug | AGN 193109 | 1.79e-05 | 31 | 5 | 2 | CID000177238 | |
| Drug | TCDF | 2.16e-05 | 34 | 5 | 2 | CID000039929 | |
| Drug | p-dioxin | 2.56e-05 | 37 | 5 | 2 | CID000078968 | |
| Drug | AC1L3U0V | 3.00e-05 | 40 | 5 | 2 | CID000122124 | |
| Drug | 2d3z | 3.15e-05 | 41 | 5 | 2 | CID009543495 | |
| Drug | tirapazamine | 3.98e-05 | 46 | 5 | 2 | CID000033776 | |
| Drug | RI-331 | 4.15e-05 | 47 | 5 | 2 | CID000160754 | |
| Drug | DB04724 | 4.33e-05 | 48 | 5 | 2 | CID005288688 | |
| Drug | bis(hexamethylene)triamine | 5.91e-05 | 56 | 5 | 2 | CID000008924 | |
| Drug | dibenzofurans | 8.23e-05 | 66 | 5 | 2 | CID000000568 | |
| Drug | DMEs | 9.53e-05 | 71 | 5 | 2 | CID003038361 | |
| Drug | CoCl2 | 1.06e-04 | 75 | 5 | 2 | CID003015678 | |
| Drug | 3'-dCTP | 1.53e-04 | 90 | 5 | 2 | CID000153054 | |
| Drug | AC1L9FY1 | 1.93e-04 | 101 | 5 | 2 | CID000444218 | |
| Drug | butylbenzyl phthalate | 2.21e-04 | 108 | 5 | 2 | ctd:C027561 | |
| Drug | alpha-naphthoflavone | 2.64e-04 | 118 | 5 | 2 | CID000011790 | |
| Drug | TBHQ | 3.76e-04 | 141 | 5 | 2 | CID000016043 | |
| Drug | cobalt(II) chloride | 4.03e-04 | 146 | 5 | 2 | CID000024288 | |
| Drug | mepyramine | 4.49e-04 | 154 | 5 | 2 | CID000004992 | |
| Drug | NSC-683864 | 5.27e-04 | 167 | 5 | 2 | CID000148191 | |
| Drug | m189 | 5.98e-04 | 178 | 5 | 2 | CID000022230 | |
| Drug | AC1NDZBW | 6.60e-04 | 187 | 5 | 2 | CID004634040 | |
| Drug | sulforaphane | 6.74e-04 | 189 | 5 | 2 | CID000005350 | |
| Drug | propofol | 6.89e-04 | 191 | 5 | 2 | CID000004943 | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; PC3; HT_HG-U133A | 7.32e-04 | 197 | 5 | 2 | 4654_UP | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; PC3; HT_HG-U133A | 7.32e-04 | 197 | 5 | 2 | 4078_UP | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 1000uM; MCF7; HG-U133A | 7.47e-04 | 199 | 5 | 2 | 4_DN | |
| Drug | beta-naphthoflavone | 7.55e-04 | 200 | 5 | 2 | CID000002361 | |
| Drug | AR E | 9.96e-04 | 230 | 5 | 2 | CID004369394 | |
| Drug | 3-methylcholanthrene | 1.00e-03 | 231 | 5 | 2 | CID000001674 | |
| Drug | cyanide | 1.21e-03 | 254 | 5 | 2 | CID000000768 | |
| Drug | chromium | 2.15e-03 | 339 | 5 | 2 | CID000023976 | |
| Drug | deferoxamine | 2.20e-03 | 343 | 5 | 2 | CID000002973 | |
| Drug | dioxin | 2.25e-03 | 347 | 5 | 2 | CID000015625 | |
| Drug | arsenite | 2.25e-03 | 347 | 5 | 2 | CID000000544 | |
| Drug | benzo(a)pyrene | 2.39e-03 | 358 | 5 | 2 | CID000002336 | |
| Drug | cobalt-60 | 2.83e-03 | 390 | 5 | 2 | CID000061492 | |
| Drug | o,p'-DDT | 3.76e-03 | 451 | 5 | 2 | ctd:C016340 | |
| Drug | afimoxifene | 4.23e-03 | 479 | 5 | 2 | ctd:C016601 | |
| Drug | NSC-364372 | 4.32e-03 | 484 | 5 | 2 | CID000435143 | |
| Drug | oxygen | 4.59e-03 | 499 | 5 | 2 | CID000000977 | |
| Disease | HDL cholesterol change measurement | 6.33e-06 | 24 | 5 | 2 | EFO_0007805 | |
| Disease | Colorectal Neoplasms | 8.62e-04 | 277 | 5 | 2 | C0009404 | |
| Disease | corneal resistance factor | 2.26e-03 | 451 | 5 | 2 | EFO_0010067 | |
| Disease | Colorectal Carcinoma | 5.39e-03 | 702 | 5 | 2 | C0009402 | |
| Disease | testosterone measurement | 1.71e-02 | 1275 | 5 | 2 | EFO_0004908 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSMRMCMGSRRSFIC | 251 | P27540 | |
| VCDRMAMMVSGTLRC | 1406 | Q8WWZ4 | |
| SMRMCMGSRRSFICR | 226 | Q9HBZ2 | |
| CMEAFGMSARRARDM | 171 | Q96CW9 | |
| FSRCFRDTTMIMIGM | 341 | Q9BY10 |